search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

¹⁹F MRI radiomic features: in vitro and in vivo repeatability.

Olga Maxouri ,
Mariah Daal ,
Serena Vegna ,
Diana Ivonne Rodríguez Sánchez ,
Sajjad Rostami ,
Stephan Ursprung ,
Manon Boeije ,
Natalie Proost ,
Marieke van de Ven ,
Leila Akkari ,
Mangala Srinivas ,
Zuhir Bodalal ,
Regina Beets-Tan

Abstract

MATERIALS AND METHODS

Two phantoms containing perfluoropolyether (PFPE) or perfluoro-15-crown-5 ether (PFCE) were repeatedly scanned (intrasession and intersession) using a 7-T system equipped with a dual-tuned ¹H/¹⁹F volume coil. Radiomic features were extracted and assessed for stability using the concordance correlation coefficient (CCC) ≥ 0.85 and normalized dynamic range ≥ 0.90. A separate in vivo test-retest experiment was conducted in tumor-bearing mice injected with a PFPE nanoemulsion.

CONCLUSION

Several ¹⁹F MRI-derived features exhibited excellent short-term repeatability, and a considerable proportion proved robust to intersession variability. These robust features may reliably capture ¹⁹F signals under both phantom and physiological conditions, paving the way for more quantitative imaging analysis in this modality and encouraging general reproducibility of data.

RESULTS

A total of 194 scans and 772 segments were evaluated across the PFPE phantom, PFCE phantom, and in vivo experiments. In both phantoms, radiomic features displayed high intrasession repeatability (median CCC up to 0.886) but decreased intersession repeatability (median CCC down to 0.683). Intensity features were consistently more repeatable (p < 0.003) than shape or texture features. We found that 23.1% (466/2,013) of features were repeatable across phantoms. In vivo pilot scans showed that 86.1% (401/466) of these phantom-stable features, or ~20.0% overall, remained repeatable under physiological conditions.

RELEVANCE STATEMENT

KEY POINTS: We analyzed 194 ¹⁹F MRI scans and 772 segments obtained in phantoms at 7 T. Cross-agent stability identified 466 radiomic features meeting concordance correlation coefficient ≥ 0.85 and normalized dynamic range ≥ 0.90. Of these phantom-stable features, 401 of 466 remained stable in vivo in a tumor mouse model. Intensity features were most repeatable, while shape features were least stable across sessions. Median concordance correlation coefficient dropped from 0.886 intrasession to 0.683 intersession.

OBJECTIVE

Using radiomics to compute quantitative imaging features may reveal information beyond standard magnetic resonance imaging (MRI) metrics. We aim to investigate the test-retest repeatability of ¹⁹F MRI radiomic features in phantoms containing two perfluorocarbons and to validate these findings in a pilot in vivo mouse tumor model.

More about this publication

European radiology experimental

Volume 10
Issue nr. 1
Publication date 16-03-2026

Full text links

Publisher website (DOI) 10.1186/s41747-026-00694-2
Europe PubMed Central 41838244
Pubmed 41838244

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.